The Society for Immunotherapy of Cancer (SITC) hosted Session 106e during the 39th Annual Meeting & Pre-Conference Programs on Friday, November 8, 2024. Available here are the presentation slides and video from “Session 106e: Commonalities and Site-Specific Factors for Immune Microenvironments across and between Tumor Types” as permitted by presenters.
F. Stephen Hodi Jr., MD – Dana-Faber Cancer Institute
Mario Sznol, MD – Yale School of Medicine
In humans, the immune component of the tumor microenvironment is likely shaped over many years. Tumor genetics and epigenetics, host genetics, and a lifetime of acute and chronic environmental exposures likely contribute to the immune composition of the tumor. These factors influence the natural history of the malignancy and its response to all forms of therapy including immune modulation. Recent data suggest that tumor immune microenvironments can be grouped into a limited number of phenotypes which could provide insights into pathogenesis and approaches to treatment. In this session, speakers will describe the spectrum of tumor immune microenvironments as revealed by analyses of histopathology, sequencing, and immune monitoring, characterizing commonalities and site-specific differences as they relate to the primary tumor site and/or site of metastases.
To view the entire program schedule (including presenter permission to post) please click here.
01:46:18